AI Summary & Key Takeaways
AI InsightAlthough there is no generally accepted standard treatment, anti-inflammatory and anti-vascular endothelial growth factor agents are necessary in the acute stage to control the inflammation and choroidal neovascularization.
📌 3 Key Takeaways
Abstract
Multifocal choroiditis is a posterior chorioretinal inflammatory disease of unknown etiology. The acute chorioretinal lesions subsequently scar with proliferation of retinal pigment epithelium and fibrosis, which may, in turn, lead to the occurrence of choroidal neovascular membranes and irreversible visual loss. Although there is no generally accepted standard treatment, anti-inflammatory and anti-vascular endothelial growth factor agents are necessary in the acute stage to control the inflammation and choroidal neovascularization.
Özet
Multifokal koroidit etiyolojisi bilinmeyen kronik posterior koryoretinal inflamatuar bir hastalıktır. Akut koryoretinal lezyonlar skar formasyonu ile iyileşerek retina pigment epitelinde proliferasyon ve fibrozise sebep olarak sekonder koroid neovasküler membrana ve kalıcı görme kaybına sebep olur. Standart tedavisi olmamakla birlikte sistemik antiinflamatuar ve intravitreal antivasküler endotelyal büyüme faktörleri akut fazda inflamasyonu ve koroid neovaskülarizayonunu kontrol altına almada etkilidir.